Filing Details

Accession Number:
0001144204-16-089106
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-03-21 12:44:36
Reporting Period:
2016-03-18
Filing Date:
2016-03-21
Accepted Time:
2016-03-21 12:44:36
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1012477 Flamel Technologies Sa FLML Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1600771 L Sandra Hatten 33, Avenue Du Docteur Georges Levy
Venissieux I0 69693
Sr. Vp, Quality & Reg Affairs No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Adss Acquisiton 2016-03-18 3,000 $11.01 3,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Adss Stock Option (right to buy) $21.67 2025-06-26 100,000 100,000 Direct
Adss Stock Option (right to buy) $14.35 2025-12-10 50,000 50,000 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2025-06-26 100,000 100,000 Direct
2025-12-10 50,000 50,000 Direct
Footnotes
  1. The issuer's "ADSs" are American Depositary Shares, with each ADS representing one ordinary share, nominal value 0.122 Euros per share, of the issuer; ADSs are represented by American Depositary Receipts.
  2. Options become exercisable as to 25,000 ADSs on each of the first four anniversaries after the 06/26/2015 grant date.
  3. Options become exercisable as to 12,500 ADSs on each of the first four anniversaries after the 12/10/2015 grant date.